Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crispin R Dass

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Trends in Pharmacological Sciences|July 28, 2004
Deoxyribozymes: cleaving a path to clinical trialsCrispin R Dass
The Journal of Pharmacy and Pharmacology|May 15, 2002
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivoCrispin R Dass
Journal of Molecular Medicine (Berlin, Germany)|June 29, 2004
Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfectionCrispin R Dass
Current Drug Targets|March 29, 2018
Editorial: Bone Drug TargetsCrispin R Dass
International Journal of Pharmaceutics|November 7, 2003
Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculatureCrispin R Dass
Biotechnology and Applied Biochemistry|April 9, 2004
Oligonucleotide delivery to tumours using macromolecular carriersCrispin R Dass
Biomedicines|July 29, 2025
PEDF and Its Role in Metabolic Disease, Angiogenesis, Cardiovascular Disease, and DiabetesCrispin R Dass
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Drug delivery in cancer using liposomesCrispin R Dass
Drug Delivery|October 25, 2002
Liposome-mediated delivery of oligodeoxynucleotides in vivoCrispin R Dass
International Journal of Pharmaceutics|June 28, 2002
Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapyCrispin R Dass
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Trends in Pharmacological Sciences|July 28, 2004
Deoxyribozymes: cleaving a path to clinical trialsCrispin R Dass
The Journal of Pharmacy and Pharmacology|May 15, 2002
Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivoCrispin R Dass
Journal of Molecular Medicine (Berlin, Germany)|June 29, 2004
Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfectionCrispin R Dass
Current Drug Targets|March 29, 2018
Editorial: Bone Drug TargetsCrispin R Dass
International Journal of Pharmaceutics|November 7, 2003
Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculatureCrispin R Dass
Biotechnology and Applied Biochemistry|April 9, 2004
Oligonucleotide delivery to tumours using macromolecular carriersCrispin R Dass
Biomedicines|July 29, 2025
PEDF and Its Role in Metabolic Disease, Angiogenesis, Cardiovascular Disease, and DiabetesCrispin R Dass
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Drug delivery in cancer using liposomesCrispin R Dass
Drug Delivery|October 25, 2002
Liposome-mediated delivery of oligodeoxynucleotides in vivoCrispin R Dass
International Journal of Pharmaceutics|June 28, 2002
Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapyCrispin R Dass
Pageof 21